Abstract: A method is for producing activated carbon. The method has the steps of carbonization of a carbon precursor by a first heat treatment to obtain char; mixing of the char with a chemical agent and a reducing agent to serve as a feedstock mixture; and activation of the feedstock mixture by a second heat treatment, wherein the chemical agent is selected from a group comprising potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, potassium oxide, and sodium oxide and wherein the reducing agent comprises a metal. An electrode has the activated carbon produced by the method. A supercapacitor has the electrode.

Abstract: The present disclosure related to encapsulated anaerobic probiotics, methods of encapsulation, food compositions and foodstuff. The present invention is useful in the food industry and allows the maintenance of viable anaerobic bacteria in food products and/or food supplements even if stored in aerobic conditions without refrigeration.

Abstract: The present invention relates to microorganism compositions and fertilisers comprising them, which reduce soil nitrate accumulation and their use for avoiding nitrogen leaching.

Abstract: A computerized system is provided including an asset registry server configured to receive an asset token template generation request, create an asset record template for a product, receive manufacturer content related to the product, store the manufacturer content associated with the asset record template, and send an asset identifier for the asset record template to a point-of-sale system. Further, the asset registry server is configured to receive an asset token request from the point-of-sale system in response to a user purchasing a product associated with the asset identifier, generate an asset token, create a new asset record in the asset record database including the generated asset token or including a link to the generated asset token on a publicly accessible ledger, and send the asset token or link to the point-of-sale system for transmission to an owner client device of the owner purchasing the product.

Abstract: A decorative tent system includes a tent structure comprising a frame and a flexible tent, wherein the tent structure covers an internal space and comprises at least one opening. The system includes an external covering external to the tent structure wherein the covering comprises a tree-like structure and wherein the external covering covers a majority of an external surface of the flexible tent. The system further includes a lighting system coupled to the tent structure and internal to the flexible tent.

Abstract: Installation for the recirculation of fresh water of the type that includes a pretreatment module for pretreating the water from an aquaculture tank, an oxidation module for the elimination of contaminants and a recirculation of the treated fresh water to the culture tank, after a post-treatment module that also passing through includes an electrochemical module for generating oxidants arranged in an auxiliary line, outside the main line for recirculating the treated fresh water, which is fed by a water recirculation line from the outlet of the post-treatment module, the electrochemical oxidant generation module being decoupled from the oxidation module and in fluid communication with it through an electrogenerated oxidant feed line.

Abstract: A method for the treatment of sludge containing iron, the method including a leaching step wherein the sludge containing iron is mixed with an acid and an oxidation agent so as to create an oxidized leachate, and a step of precipitation of iron wherein the oxidized leachate is mixed with a neutralizing agent so as to create a mixture composed of a solid part including precipitated iron and of a liquid part, the neutralizing agent including at least 30% in weight of dust recovered from a bag filter treatment of ironmaking, steelmaking, coke making or sintering gas.

Abstract: The proposed invention relates to an electromedical device that produces a cold plasma at atmospheric pressure for use in blood clotting and the treatment of ulcers and other skin injuries in human and animal patients. The main claims relate to the use of gas pre-treated by means of a cooling and dehumidification, together with a system of plasma expansion chambers in the outlet channel of same. As a result of these innovations, the plasma produced using the invention has a lower temperature than those in the prior art, preserving greater effectiveness both in blood clotting and in the disinfection and treatment of skin injuries, without causing any damage to the patient's healthy tissue. The device can be used in the treatment of human and animal patients to considerably accelerate blood clotting without damage to healthy tissue, during clinical and surgical treatments. I can also be used to treat ulcers and other skin injuries, owing to its disinfection properties, without damaging healthy tissue.

Abstract: A conversational agent is provided for maintaining or improving the wellbeing of a user presenting with diabetes and mental health needs by the delivery of a care protocol. The conversational agent comprises: a plurality of sub-dialogue units, each configured to deliver an element of the care protocol, and an orchestrator configured to present the sub-dialogue units to the user, sequentially, wherein each sub-dialogue unit and the orchestrator comprises: a natural language understanding module configured to receive an input and/or reply and determine at least one intent and, where present, at least one slot within the input and/or reply: a dialogue planning module configured to determine an output based, at least in part, on the at least one intent and/or slot associated within the input and/or reply, and a natural language generation module configured to provide the output to the user.

Abstract: The present invention relates to retromer complex activators and compositions for use in the treatment and/or prevention of neurological and psychiatric disorders characterized by Kidins220 dysfunction in a subject. These disorders may be further characterized by ventriculomegaly and/or excitotoxicity. It also relates to methods for screening a retromer complex activator for use in the treatment and/or prevention of said disorders in a subject.

Abstract: An adhesive, waterproofing, and sealing glue, with natural components, and the process to obtain it, based on the use of whey residues from the cheese industry and the pruning residue of Opuntia ficus-indica, a species with low water consumption, to which acetic acid, corn starch, sucrose, sodium bicarbonate, and traces of calcium silicate and boric salts are added. It is obtained through the process disclosed, natural glue that cements with sufficient adhesive and filling power, with proven mechanical strength, good texture and waterproofing finish, and with adequate micro-porosity for the breathability of the product. This glue is particularly useful for the construction industry, in the manufacture of laminated panels from cellulosic components, whether they are multi-laminated panels or those made from particle conglomerates.

Abstract: A conversational agent is provided for maintaining or improving the wellbeing of a user presenting with mental health needs by the delivery of a care protocol. The conversational agent comprises: a plurality of sub-dialogue units, each configured to deliver an element of the care protocol, and an orchestrator configured to present the sub-dialogue units to the user, sequentially, wherein each sub-dialogue unit and the orchestrator comprises: a natural language understanding module configured to receive an input and/or reply and determine at least one intent and, where present, at least one slot within the input and/or reply; a dialogue planning module configured to determine an output based, at least in part, on the at least one intent and/or slot associated within the input and/or reply, and a natural language generation module configured to provide the output to the user.

Abstract: This disclosure provides a method of stabilizing the interaction of a Retinoic Acid Receptor-alpha (RAR?) and a corepressor, Nuclear Receptor Corepressor 1 (NCoR1) by contacting the RARa with an amount of a Chaperone Mediated Autophagy (CMA) Activator sufficient to stabilize the RAR?-NCoR1 interaction. Stabilizing the RAR?/corepressor interaction can prevent a neurodegenerative disorder in a subject at risk for developing the neurodegenerative disorder or slow the advancement of a neurodegenerative disorder in a subject having an early symptom or biomarker of the neurodegenerative disorder. The disclosure also provides a method of maintaining preventing or slowing the advancement of a retinal degenerative disorder in a subject having an early symptom or biomarker of the retinal degenerative disorder.

Abstract: The disclosure provides method of enhancing neuronal, vascular cell, and macrophage proteostasis, in a subject by administering a CMA activator to the subject. Enhancing proteostasis is a method of preventing or slowing advancement of an age-related neurodegenerative disease, atherosclerosis, or an inflammatory disease in a subject. The age related neurodegenerative disease can be Alzheimer A disease (AD), Lewy body dementia, Parkinson's disease (PD), Huntington's disease, Amyotrophic lateral sclerosis (ALS), Frontotemporal dementia (FTD). Spinocerebellar ataxias (SC As), or Progressive subcortical gliosis. The disclosure further provides a method of reducing the progression of beta-amyloid and/or tau pathology in the subject, and/or reduces pre-existing beta-amyloid and/or tau pathology in the subject.

Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.

Abstract: Aspects of the disclosure include a natural language processing model by which topics of interest within a text are identified, such as by a predictive model that infers (e.g., based on scores associated with a text) a topic of interest associated with the text. The computer system may train or configure the prediction model, such as a machine learning model, to facilitate identification of topics of interest based on inputs, like one or more chunks of text, such as by keywords or phrases or combinations of keywords and associated metrics for nearness or frequency. The computer system may determine a measure of predicted impactfulness of the content item in relation to a topic of interest identified for the content item and determine whether to generate a notification transmitted to client devices of users having indicated the topic as of interest.

Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.

Abstract: The present disclosure provides methods of treating disease and disorders of the hematological system. The disclosure provides a method of expanding a population of hematopoietic stem cells (HSCs) while maintaining the population in an undifferentiated state comprising contacting the population of HSCs in the presence of a CMA activator for a period of time until a sufficient number of HSCs is obtained thereby producing an expanded HSC population.

Abstract: VOCs in exhaled breath can be used to diagnose stage 1 lung cancer (SL1C). Three potential biomarkers Acetoin, Dodecane, and p-Cymene have predictive power for SL1C. Acetoin and Dodecane are predictive with relation to their concentrations in the 1 L breath sample, and p-Cymene is predictive 5 with relation to being above or below the limit of detection. The diagnostic of the present invention is capable of detecting S1LC noninvasively and in some cases earlier than other methodologies. This diagnostic can then be paired with appropriate treatments to address S1LC before it grows or metastasizes.